biOasis Receives Compelling Data From Texas Tech University On Its Herceptin(R) BT2111 Program - Yahoo! Finance
|
biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that research underway at Texas Tech University Health Sciences Center (TTUHSC) has yielded some compelling data on preclinical studies designed to evaluate the pharmacokinetics of BT2111 (a proprietary conjugate of Transcend and Herceptin®) in animal models of breast cancer metastasis to the brain. Read the full story >> |
Related Stories
How Does Your Garden Grow?
As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.
Adopt a Growth Mindset for a Better Life
A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.
Drug Use, Family History Can Lead to Heart Disease in Younger Adults
Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.
Recent Stories
TTUHSC Faculty Receive Chancellor’s Council Distinguished Teaching and Research Awards
Recognizing academic excellence, the honors are the most prestigious awards granted to faculty throughout the TTU System. The awards are funded by gifts to the Chancellor’s Council, a giving society that supports the chancellor’s priorities across the TTU System.
Free Clinic Offered for Women’s Health Day
TTUHSC School of Medicine students will host a Women’s Health Day free clinic from 10 a.m. to 1 p.m. April 15 at The Free Clinic
Researchers Study the Impact of Cancer on Hispanic Patients and Their Caregivers
TTUHSC Cytogenetic Technologist Jasbir Bisht and a team from P. Hemachandra Reddy’s internal medicine laboratory analyzed the impact of cancer in Hispanics in comparison to other ethnic groups.